SLC5A1 and COVID-19: Moreover, the dysregulation of the sodium-dependent glucose transporter (SGLT1 or SLC5A1) in the intestinal epithelium, controlled by ACE2, has been linked to the pathogenesis of diabetes mellitus, which may contribute to the higher mortality observed in COVID-19 patients with diabetes [29].